Onesource Specialty Pharma Board Meeting on Oct 27 for Q2 FY27 Results

Onesource Specialty Pharma Ltd has announced that its Board of Directors will convene on October 27, 2026. The primary agenda item is to consider and approve the unaudited financial results, both standalone and consolidated, for the quarter ended September 30, 2026. Additionally, the company has closed its trading window for designated persons from October 1, 2026, which will reopen 48 hours after the financial results are disseminated, in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015.